Patent · US Active

Liquid dosage forms of Imatinib

US11957681B2 · kind B2 · utility

0Cited by

0References

1Claims

0Family size

Assignee

SHORLA PHARMA LTD. · IE

Inventors

Sandip P. Mehta · Ahmedabad, IN
Vijay Patel · Loughborough, GB
Manish Umrethia · Ahmedabad, IN
Jayanta Kumar MANDAL · Ahmedabad, IN

Key dates

Filing date	Jul 26, 2018
Grant date	Apr 16, 2024
Priority date	—
Expiry date	Apr 27, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/36
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Imatinib is approved and marketed in solid oral dosage forms which may be dispersed in water or apple juice for patients having swallowing difficulty. Dispersion of Imatinib solid dosage forms in apple juice may increase palatability and patient compliance but apple juice may not be available all the time for administration. Further, dispersion of Imatinib solid oral dosage forms may not administer correct and consistent dose of medicine every time. The present invention therefore provides liquid dosage forms of Imatinib which correctly and consistently administers correct dose of drug to the patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.